接受放射性碘治疗患者的家庭成员所受估计剂量。

Estimated Dose to Family Members of Patients Treated with Radioiodine.

作者信息

Kochovska Marina Zdraveska, Jokic Vesna Spasic, Majstorov Venjamin, Dugonjic Sanja

机构信息

Institute of pathophysiology and nuclear medicine, Vodnjanska 17, 1000 Skopje, Republic of Macedonia.

Department of Power, Electronics and Telecommunication, University of Novi Sad, Trg Dositeja Obradovica 6, 21000 Novi Sad, Republic of Serbia.

出版信息

Radiat Prot Dosimetry. 2017 Apr 25;174(2):250-254. doi: 10.1093/rpd/ncw138.

DOI:10.1093/rpd/ncw138

PMID:27247441

Abstract

Patients who receive therapeutic amount of 131I are potentially significant source of radiation to their family members and general public. The aim of this study was to estimate effective dose to family members of patients treated with radioiodine, released after 3 d of hospitalization and to compare with dose constraints proposed by international recommendations. The thermoluminescence dosemeters (TLD 100) and Radiation Dose Assessment Resource (RADAR) software were used for assessment of effective doses to 60 family members of the same number of hyperthyroid and thyroid carcinoma patients. Estimated effective doses were well below recommended dose limits except in a few cases. RADAR-calculated doses were higher than doses measured by TLD. Hyperthyroid patients should continue to be treated on outpatient basis but they should be well informed for their further behavior to provide minimal radiation hazard for the people in their environment.

摘要

接受治疗剂量¹³¹I的患者对其家庭成员和普通公众而言可能是重要的辐射源。本研究的目的是估算放射性碘治疗患者在住院3天后出院时其家庭成员所接受的有效剂量，并与国际建议提出的剂量限制进行比较。使用热释光剂量计（TLD 100）和辐射剂量评估资源（RADAR）软件对相同数量的甲状腺功能亢进症患者和甲状腺癌患者的60名家庭成员的有效剂量进行评估。除少数情况外，估算的有效剂量远低于推荐剂量限值。RADAR计算的剂量高于TLD测量的剂量。甲状腺功能亢进症患者应继续在门诊接受治疗，但应充分告知他们后续行为，以便为周围的人提供最小的辐射危害。